Sign In
Buy SAVA
$1.96
+0 (+0%)
At Close: Jun 03, 2026
Why Cassava Sciences' Stock Is Getting Hammered Today
08:41am, Wednesday, 25'th Aug 2021
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading lower on negative claims that were posted online yesterday after market hours. The company issued a response to the claims today, saying they b
SAVA Stock: Over 20% Decrease Pre-Market Explanation
07:45am, Wednesday, 25'th Aug 2021
The stock price of Cassava Sciences Inc (NASDAQ: SAVA) fell by over 20% pre-market. This is why it happened.
Cassava Sciences stock tumbles, and company responds to allegations disputing trial data
06:37am, Wednesday, 25'th Aug 2021
Cassava Sciences Inc. SAVA, +1.92% responded Wednesday to allegations posted overnight regarding the "accuracy and integrity" of trial data for its treatment of Alzheimer's disease, saying it believed
Cassava Sciences Responds to Allegations
06:00am, Wednesday, 25'th Aug 2021
AUSTIN, Texas, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer's disease, today issued a response to claims that were posted on-li
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
12:55am, Wednesday, 25'th Aug 2021
BENSALEM, Pa.--(BUSINESS WIRE)---- $SAVA #ClassAction--Law Offices of Howard G. Smith Announces Investigation of Cassava Sciences, Inc. (SAVA)
Cassava Sciences Has an Admirable Goal at Too High a Price
04:31pm, Tuesday, 24'th Aug 2021
It would be great if Cassava Sciences' treatment for Alzheimer's disease worked, but should you pay the high price for SAVA stock? No. The post Cassava Sciences Has an Admirable Goal at Too High a Pri
5 Penny Stocks That Turned $2,500 Into Over $29,000 In 2021 So Far
11:28am, Tuesday, 24'th Aug 2021
Hot Penny Stocks That Scored Huge For Traders In 2021 The post 5 Penny Stocks That Turned $2,500 Into Over $29,000 In 2021 So Far appeared first on Penny Stocks to Buy, Picks, News and Information | P
Phase 3 Study Initiation Still Expected Fall 2021 Phase 3 Study Initiation Still Expected Fall 2021
Soaring Cassava Sciences Stock Shows Unfettered Promise for Growth
11:40am, Friday, 20'th Aug 2021
With more than 6 million people in the U.S. suffering from Alzheimer's disease, SAVA stock has enormous potential for future profits. The post Soaring Cassava Sciences Stock Shows Unfettered Promise f
Cassava Sciences Stock Has Had an Epic Run, but Getting in Now Is a Serious Risk
12:02pm, Thursday, 19'th Aug 2021
Given it's at risk of a severe pullback if it stumbles going forward? If you own, take some risk off the table, by partially paring down your position.
These Are the Top Reasons You Should Load Up on Cassava Sciences Stock
06:00am, Wednesday, 18'th Aug 2021
At the moment, there's no cure for Alzheimer's, but Cassava Sciences is working to wipe it out for good making SAVA stock a buy here. The post These Are the Top Reasons You Should Load Up on Cassava S
With This Exciting Alzheimer's Treatment, Cassava Sciences Stock Has Legs
06:00am, Monday, 16'th Aug 2021
Incredible Alzheimer's data suggests that Cassava has the right approach to tackling the disease powering SAVA stock The post With This Exciting Alzheimer's Treatment, Cassava Sciences Stock Has Legs
Cassaca Sciences Stock Is a Buy on the Strength of a Promising Alzheimer's Drug
06:00am, Monday, 16'th Aug 2021
Skeptics are wrong about Cassava's Alzheimer's drug, as the drug's data is superb. Long-term investors should buy SAVA stock.
Why Might Cassava Succeed With Its Alzheimer's Drug, When So Many Have Failed?
05:39am, Saturday, 14'th Aug 2021
Alzheimer's research has been hampered by apparently mistaken ideas about what causes the disease. Cassava has a new theory about what's responsible -- and its drug is showing positive results.
Analyzing the Potential Risks of Cassava Sciences
06:00am, Friday, 13'th Aug 2021
Cassava Sciences has a promising drug candidate for Alzheimer's. However, SAVA stock may be overpriced based on the limited data so far.
